Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mees Egeler MSc

Mees Egeler MSc

PhD Candidate, Epidemiology and Psychosocial Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands

Mees Egeler is a PhD candidate at the Netherlands Cancer Institute. His research focuses on measuring health-related quality of life (HRQoL) in patients with stage III/IV melanoma and developing the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) for Advanced Melanoma (EORTC-QLQ-AM) for use in international clinical trials.